Training Program Intervention
BehavioralResident or NP Student receives the educational intervention during 8 half-day sessions.
NCT Number: NCT00687349
This research study is a randomized trial to evaluate a training program that is designed to improve the communication skills of clinicians. The training program focuses on care for patients with serious illnesses and their family members, and assesses effectiveness using patient and family outcomes. The long term goal of this research is to improve communication skills of doctors and nurses, thereby improving patient and family outcomes.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Medical University of South Carolina, Charleston, South Carolina, United States
Three decades of research on end-of-life care in the United States indicates that people who are dying often spend their final days with a significant burden of pain and other symptoms and receive care they would not choose. Patient-clinician communication about end-of-life care is an important focus for improving patient-centered end-of-life care for three reasons: 1) it is an integral component of clinician skill that affects all other aspects of end-of-life care; 2) physicians and nurses in practice do not demonstrate adequate skills for communicating about end-of-life care; and 3) current training in end-of-life communication is inadequate. Studies have shown that clinicians can improve their communication skills with experiential training, but no studies to date have shown that an intervention to improve clinician communication skill improves patient outcomes. Furthermore, despite widespread knowledge that end-of-life care is best delivered in an interdisciplinary context, most studies do not incorporate interdisciplinary training that includes physicians and nurses.
This is a randomized trial of a communication skills workshop for internal medicine residents and nurse practitioner (NP) students. A total of 373 residents and 128 NP students from two large training programs (UW and MUSC) will be randomized to either the intervention or usual education. The study's primary outcome measure will be the QOC scores on the "communication about end-of-life care" domain. The QOC will be assessed by patients, family members, and nurses before and after the intervention time period for all trainees. Secondary outcome measures are patient symptoms and patient-, family - and nurse-assessed QEOLC scores. Outcome measures will be collected for 5 patients and family members per trainee before the intervention period and 5 patients and family members per trainee after the intervention period. Process measures for both residents and NP students will include pre- and post-intervention assessment of knowledge, attitudes, and behavior regarding communication using standardized patient assessment as well as self-assessment and faculty assessment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Physician:
NP Student:
Patient:
One or more of the following diagnostic criteria:
Family:
Nurse-evaluators:
Exclusion criteria
Resident or NP Student receives the educational intervention during 8 half-day sessions.
Time frame: 4/1/2007-3/31/2012
Time frame: 4/01/2007-3/31/2012
Time frame: 4/01/2007-3/31/2012
University of Washington
Other
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Acronym: ICCS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737899
Advanced Cancer, Chronic Disease
Coimbra, Portugal
View Trial DetailsNCT04864418
Advanced Cancer
Seoul, South Korea
View Trial DetailsNCT07712237
Advanced Cancer
Taipei, Taipei City, Taiwan
View Trial DetailsNCT06722014
Advanced Cancer, Mental Disorders
Boston, Massachusetts, United States
View Trial Details